Guide price only. Final cost is confirmed after assessment.
Ostenil Injection offers a cutting-edge approach to managing joint pain associated with osteoarthritis. At London Cartilage Clinic, we utilise this hyaluronic acid-based treatment to provide relief and improve joint function for our patients, ensuring an enhanced quality of life.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026
Ostenil replenishes hyaluronic acid in arthritic joints to improve lubrication, absorb load, and reduce painful friction during movement.
It is typically considered as part of an overall osteoarthritis management strategy including activity modification and rehabilitation.
The value of Ostenil depends on precise indication and injection technique. Our team focuses on making sure the right patient receives the right product at the right time.
At London Cartilage Clinic, Ostenil is delivered within a comprehensive joint-care pathway focused on practical pain relief, function, and long-term joint preservation.
The relief from Ostenil Injection can last for several months, varying from patient to patient. Its long-lasting effect is one of the key benefits of this treatment.
Ostenil Injection is effective in various joints affected by osteoarthritis, not just the knee. It’s important to consult with our specialists to determine the best treatment plan for your condition.
Ostenil Injection is generally well-tolerated, with minimal risks. Any potential side effects or concerns can be discussed during your consultation with our experts.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
ChondroFiller lasts substantially longer — 70–85% sustain meaningful relief for three to five years versus six to twelve months for hyaluronic acid — but only because each addresses different pathology: focal cartilage defects through endogenous cell recruitment versus diffuse osteoarthritis through synovial lubrication.
The ChondroFiller injection itself takes minutes, but the regeneration it triggers spans 12–24 months as progenitor cells migrate into the collagen scaffold and gradually replace it with mature cartilage tissue.
When ChondroFiller is injected into the joint, it undergoes pH-triggered gelation; the resulting scaffold recruits the body's own repair cells whilst suppressing MMP-13, the primary cartilage-destroying enzyme.
